Under certain circumstances, a rare tropical plant develops into a carnivore. A research team from the universities of Hannover and Würzburg has now deciphered the mechanism responsible for this.
Plants & Animals
May 16, 2023
0
529
Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer—one of the most aggressive and difficult to treat cancers—by delivering immunotherapy directly into the tumor with a device that is ...
Bio & Medicine
Apr 13, 2023
0
1802
A research team led by Dr. Ho Sang Jung of the Surface & Nano Materials Division of the Korea Institute of Materials Science (KIMS), a research institute under the Ministry of Science and ICT, conducted joint research with ...
Bio & Medicine
Feb 14, 2023
0
147
A group lead by Prof. Horacio Cabral (Visiting Scientist of iCONM/Associate Professor of Bioengineering, Graduate School of Engineering, University of Tokyo) has discovered a new approach for the treatment of triple-negative ...
Bio & Medicine
Dec 6, 2022
0
30
University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study published today.
Bio & Medicine
Nov 24, 2022
0
92
Colorectal cancer (CRC) has emerged as a frequently diagnosed disease. Advanced CRCs are highly heterogenous and often evade treatments, building drug resistance and reoccurring.
Bio & Medicine
Nov 10, 2022
0
4
Nanoparticles, or tiny molecules that can deliver a payload of drug treatments and other agents, show great promise for treating cancers. Scientists can build them in various shapes with different materials, often as porous, ...
Bio & Medicine
Oct 27, 2022
0
55
A nanoparticle therapy developed by investigators at University Hospitals (UH) and Case Western Reserve University targets overactive neutrophils, a specific kind of white blood cell, to prevent almost all types of blood ...
Bio & Medicine
Sep 30, 2022
0
88
The maintenance of a healthy cell population is a dynamic process, whereby unhealthy cells are eliminated by a defense mechanism called cell competition. This process is crucial as unhealthy cells or cells that have accumulated ...
Cell & Microbiology
Sep 19, 2022
0
46
Over the past 30 years, progress in early detection and treatment of cancer has helped reduce the overall death rate by more than 30%. Pancreatic cancer, however, has remained difficult to treat. Only 1 in 9 people survive ...
Bio & Medicine
Sep 13, 2022
0
199
Pancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still extremely rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas. Exocrine pancreatic cancers are far more common than endocrine pancreatic cancers (islet cell carcinomas), which make up about 1% of total cases.
This text uses material from Wikipedia, licensed under CC BY-SA
